Akebia Therapeutics Inc (AKBA)
1.37
+0.07
(+5.38%)
USD |
NASDAQ |
May 03, 16:00
1.42
+0.05
(+3.65%)
After-Hours: 20:00
Akebia Therapeutics Max Drawdown (5Y): 98.40% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 98.40% |
March 31, 2024 | 98.40% |
February 29, 2024 | 98.40% |
January 31, 2024 | 98.40% |
December 31, 2023 | 98.40% |
November 30, 2023 | 98.40% |
October 31, 2023 | 98.40% |
September 30, 2023 | 98.40% |
August 31, 2023 | 98.40% |
July 31, 2023 | 98.40% |
June 30, 2023 | 98.40% |
May 31, 2023 | 98.40% |
April 30, 2023 | 98.40% |
March 31, 2023 | 98.40% |
February 28, 2023 | 98.40% |
January 31, 2023 | 98.40% |
December 31, 2022 | 98.40% |
November 30, 2022 | 98.40% |
October 31, 2022 | 98.39% |
September 30, 2022 | 98.39% |
August 31, 2022 | 98.39% |
July 31, 2022 | 98.39% |
June 30, 2022 | 98.39% |
May 31, 2022 | 98.39% |
April 30, 2022 | 97.89% |
Date | Value |
---|---|
March 31, 2022 | 96.35% |
February 28, 2022 | 91.15% |
January 31, 2022 | 90.70% |
December 31, 2021 | 88.71% |
November 30, 2021 | 88.71% |
October 31, 2021 | 88.71% |
September 30, 2021 | 88.71% |
August 31, 2021 | 88.71% |
July 31, 2021 | 88.71% |
June 30, 2021 | 88.71% |
May 31, 2021 | 88.71% |
April 30, 2021 | 88.71% |
March 31, 2021 | 88.71% |
February 28, 2021 | 88.71% |
January 31, 2021 | 88.71% |
December 31, 2020 | 88.71% |
November 30, 2020 | 88.71% |
October 31, 2020 | 88.71% |
September 30, 2020 | 87.85% |
August 31, 2020 | 84.21% |
July 31, 2020 | 84.21% |
June 30, 2020 | 84.21% |
May 31, 2020 | 84.21% |
April 30, 2020 | 84.21% |
March 31, 2020 | 84.21% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
82.86%
Minimum
May 2019
98.40%
Maximum
Nov 2022
91.70%
Average
88.71%
Median
Oct 2020
Max Drawdown (5Y) Benchmarks
Ocugen Inc | 99.96% |
Aquestive Therapeutics Inc | 96.68% |
SELLAS Life Sciences Group Inc | 100.00% |
Protagonist Therapeutics Inc | 85.79% |
Stoke Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -39.42 |
Beta (5Y) | 0.9394 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 110.8% |
Historical Sharpe Ratio (5Y) | -0.2614 |
Historical Sortino (5Y) | -0.4449 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.87% |